New trial: Umbilical-derived stem cells for knee cartilage
This small German biotech company is joining the knee OA stem cell race.
Category: Trials
Stem cell-based alternative to in vitro maturation reports double the pregnancy rate
The company uses iPSCs to create a replica environment for maturing eggs ex vivo, and the data looks promising as they roll into Phase 3.
Organ donor? That may include using your stem cells: first successful transplant using deceased donor in blood Cancer clinical trial
It's interesting to consider, much like with umbilical cords, how often are we incinerating life-saving stem cells?
Parkinson’s stem cell trial launches: Aspen Neuroscience doses first patient with iPSCs
A new milestone for iPSC therapy in the USA, this is one to watch.
FDA approves IV adipose stem cell trial for Crohn’s disease, a Phase 2b from L2 Bio
What appears to be a small stem cell banking company is working on expanded adipose stem cell therapy for various autoimmune conditions.
New Study: Extracellular Vesicles in Fibrin Gel for Cartilage Repair (Italy)
The Italian researchers will do a 51 person trial with MSC-derived EVs in PRP-derived fibrin gels.
New Study: Intrathecal Umbilical Stem Cells + Transcutaneous Stimulation for Spinal Cord Injury
The neurorehabilitation hospital in Spain will investigate if allogeneic umbilical-derived stem cell therapy can help enhance recovery.
Hematopoietic Stem Cell-Directed Gene Insertion Therapy Gets IND Clearance
With FDA clearance secured, Ensoma prepares to launch its Phase 1/2 clinical trial to establish safety, efficacy, and dosing.
Safety and Efficacy of Epicardial Implantation of Collagen Membranes with Allogeneic Adipose-Derived Stem Cells (Cardiomesh)
This study will evaluate if the VB-C01 cellularised patch, a collagen membrane seeded with allogeneic adipose-derived stem cells, is safe and effective for surgical epicardial implantation in patients undergoing coronary artery bypass...
iPSC-Derived Motor Neuron Cells’ Dose Escalation Trial for Subacute Spinal Cord Injury, a Phase I
This study will evaluate if allogeneic human induced pluripotent stem cell (iPSC)-derived motor neuron progenitor cells (XS228, made by XellSmart) can safely and effectively treat subacute spinal cord injury. Researchers at the...
